Notable Investors / Q1 2026
Ken Fisher’s Portfolio — Fisher Asset Management, LLC
Founder & Executive Chairman, Fisher Investments
CIK 0000850529 · 6500 INTERNATIONAL PARKWAY, PLANO, TX, 75093 · 650-851-3334
About Ken Fisher
Ken Fisher built Fisher Investments into one of the largest independent RIAs in the world, wrote the long-running Forbes 'Portfolio Strategy' column, and pioneered the price-to-sales ratio in his book Super Stocks.
Fisher's giant 13F reflects managed-account scale: broad, benchmark-aware exposure across mega-cap tech, financials, and international ADRs — a barometer of mainstream advised wealth more than a concentrated bet sheet.
Portfolio data below is from Fisher Asset Management, LLC’s SEC 13F filings. View the full filer page →
Summary
Fisher Asset Management, LLC reported $294.9B in U.S.-listed holdings across 1,016 positions for Q1 2026.
Its largest position, NVDA, represents 5.2% of the portfolio.
Compared with Q4 2025, the fund opened 118 new positions and exited 119.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 68.3% · $201.3B
- ADR · 13.8% · $40.6B
- ETP · 11.4% · $33.5B
- Other · 6.2% · $18.4B
- REIT · 0.4% · $1.0B
- Other · 0.0% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ASTRAZENECA PLC | NEW | +10.85M | 10.85M | +$2.1B | $2.1B |
| PBB WORLD BIOPHARMA ETF | NEW | +28.04M | 28.04M | +$717M | $717M |
| PBB GLOBAL OIL GAS EP ETF | NEW | +19.07M | 19.07M | +$676M | $676M |
| PBB EUROPE BANKS ETF | NEW | +15.88M | 15.88M | +$436M | $436M |
| PIPRPIPER SANDLER COMPANIES COM NE | NEW | +1.08M | 1.08M | +$83M | $83M |
| CGONCG ONCOLOGY INC | NEW | +465.0K | 465.0K | +$31M | $31M |
| PNFPPINNACLE FINL PARTNERS INC COM | NEW | +173.5K | 173.5K | +$15M | $15M |
| RYNRAYONIER INC | NEW | +421.6K | 421.6K | +$9M | $9M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $294.9B | 1,016 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $293.0B | 1,017 | Feb 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $276.3B | 1,014 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $251.9B | 986 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $231.0B | 999 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $251.3B | 975 | Feb 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $244.0B | 919 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $229.9B | 986 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $214.1B | 964 | May 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $203.1B | 1,161 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | Under review | 1,168 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $181M | 1,169 | Aug 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $165M | 1,144 | May 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 1,025 | Feb 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $133.4B | 1,079 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $141.3B | 1,066 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $169.5B | 1,087 | May 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $178.6B | 1,067 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $161.0B | 1,028 | Oct 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $159.3B | 1,010 | Jul 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $142.0B | 999 | Apr 27, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $133.5B | 1,010 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $114.3B | 940 | Nov 12, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $102.5B | 902 | Aug 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $80.6B | 866 | Apr 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $99.0B | 898 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $91.1B | 903 | Oct 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $90.5B | 902 | Jul 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $85.3B | 862 | Apr 22, 2019 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2018 | $73.2B | 866 | Jan 25, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.